Agios Pharmaceuticals, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
SAM.gov UEIKKWAB4MN58M3
Agios develops therapies for rare diseases, specifically focusing on pyruvate kinase deficiency, thalassemia, and sickle cell disease. The company works in the field of cellular metabolism to create medicines for patients with these conditions. No certifications are named in the text.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Agios Pharmaceuticals, INC. | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.